pI: 6.2803 |
Length (AA): 1091 |
MW (Da): 119697 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
52 | 193 | 5cwk (A) | 23 | 165 | 18.00 | 0 | 0.42 | 0.441456 | -1.76 |
118 | 296 | 2fkj (A) | 103 | 275 | 28.00 | 0.033 | 0.07 | 0.20887 | 0.52 |
356 | 1059 | 1x9n (A) | 263 | 900 | 37.00 | 0 | 1 | 0.90948 | 0.37 |
372 | 576 | 4htp (A) | 11 | 227 | 17.00 | 0 | 0.63 | 0.343201 | -0.4 |
644 | 1090 | 3kyh (C) | 13 | 413 | 16.00 | 0 | 0.71 | 0.0100159 | 1.84 |
710 | 1061 | 4eq5 (A) | 232 | 566 | 24.00 | 0 | 1 | 0.54284 | 0.21 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127375)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G08130 | DNA ligase 1 |
Arabidopsis thaliana | AT1G49250 | ATP-dependent DNA ligase |
Babesia bovis | BBOV_IV001520 | DNA ligase I |
Brugia malayi | Bm1_26765 | DNA ligase |
Candida albicans | CaO19.6155 | DNA ligase |
Caenorhabditis elegans | CELE_C29A12.3 | Protein LIG-1, isoform B |
Cryptosporidium hominis | Chro.30432 | hypothetical protein |
Cryptosporidium parvum | cgd3_3820 | DNA LIGASE I |
Dictyostelium discoideum | DDB_G0274493 | DNA ligase I |
Drosophila melanogaster | Dmel_CG5602 | DNA ligase I |
Echinococcus granulosus | EgrG_000614700 | DNA ligase 1 |
Entamoeba histolytica | EHI_111060 | DNA ligase, putative |
Echinococcus multilocularis | EmuJ_000614700 | DNA ligase 1 |
Giardia lamblia | GL50803_7649 | DNA ligase |
Homo sapiens | ENSG00000105486 | ligase I, DNA, ATP-dependent |
Leishmania braziliensis | LbrM.30.3480 | DNA ligase I, putative |
Leishmania donovani | LdBPK_303490.1 | DNA ligase I, putative |
Leishmania infantum | LinJ.30.3490 | DNA ligase I, putative |
Leishmania major | LmjF.30.3440 | DNA ligase I, putative |
Leishmania mexicana | LmxM.29.3440 | DNA ligase I, putative |
Loa Loa (eye worm) | LOAG_06875 | DNA ligase |
Mus musculus | ENSMUSG00000056394 | ligase I, DNA, ATP-dependent |
Mycobacterium tuberculosis | Rv3062 | Probable ATP-dependent DNA ligase LigB (polydeoxyribonucleotide synthase [ATP]) (polynucleotide ligase [ATP]) (sealase) (DNA rep |
Mycobacterium ulcerans | MUL_3413 | ATP-dependent DNA ligase |
Neospora caninum | NCLIV_003210 | DNA ligase (Polydeoxyribonucleotide synthase [ATP])(Lig(Tk)) (EC 6.5.1.1), related |
Oryza sativa | 4348965 | Os10g0489200 |
Plasmodium berghei | PBANKA_1402600 | DNA ligase I, putative |
Plasmodium falciparum | PF3D7_1304100 | DNA ligase I |
Plasmodium knowlesi | PKNH_1404300 | DNA ligase I, putative |
Plasmodium vivax | PVX_122045 | DNA ligase I, putative |
Plasmodium yoelii | PY01533 | DNA ligase 1 |
Saccharomyces cerevisiae | YDL164C | DNA ligase (ATP) CDC9 |
Schistosoma japonicum | Sjp_0300290 | ko:K01971 DNA ligase (ATP) [EC6.5.1.1], putative |
Schistosoma mansoni | Smp_019840.1 | DNA ligase I |
Schistosoma mansoni | Smp_019840.2 | DNA ligase I |
Schmidtea mediterranea | mk4.002204.01 | DNA ligase 1 |
Schmidtea mediterranea | mk4.002204.02 | |
Trypanosoma brucei gambiense | Tbg972.6.4610 | DNA ligase I, putative |
Trypanosoma brucei | Tb927.6.4780 | DNA ligase I, putative |
Trypanosoma cruzi | TcCLB.506945.80 | DNA ligase I, putative |
Trypanosoma cruzi | TcCLB.506835.120 | DNA ligase I, putative |
Toxoplasma gondii | TGME49_208580 | DNA ligase 1, putative |
Theileria parva | TP03_0549 | DNA ligase I, putative |
Trichomonas vaginalis | TVAG_162990 | DNA ligase IV, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.4780 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.4780 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.4780 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.6.4780 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C29A12.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C29A12.3 | Caenorhabditis elegans | sterile | wormbase |
YDL164C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1402600 | Plasmodium berghei | Essential | plasmo |
TGME49_208580 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | ligase I, DNA, ATP-dependent | Compounds | References |